The Second Summit on Controversies in Precision Medicine - Designer Genes for Health will take place in Berlin, 19-21 November 2018.
Under the leadership of Professor Dan Peer, Director of Tel Aviv University Cancer Biology Research Center and Translational Medicine, the summit will provide a focused environment for transforming Precision Medicine. It aims to convert contemporary controversies and challenges - faced by clinicians, scientists, pharmaceutical industries and patients - into working solutions.
The building blocks of the programme include plenary talks, scientific debates, and discussions designed to maximise interaction, engagement, open-talks and networking, between all participants and the Faculty of prominent scientific and industry leaders.
Benefit from the exciting opportunity to explore in depth the present challenges and look at the future ways to increase the productivity of biopharmaceutical and clinical innovation, in a realistic and non-biased manner.
Join senior level attendees from leading industry companies, academia and government institutions in Berlin this November to innovate strategically in precision medicine!
The Scientific Advisory Board
Prof. Dan Peer, Israel
Christian Elze, London
Gianni Gromo MD PhD, Switzerland
Prof. Dr Michael Heuser, Germany
Early Registration Deadline: 20 August 2018
For support and exhibition opportunities please visit: https://goo.gl/BVk9XV
Under the leadership of Professor Dan Peer, Director of Tel Aviv University Cancer Biology Research Center and Translational Medicine, the summit will provide a focused environment for transforming Precision Medicine. It aims to convert contemporary controversies and challenges - faced by clinicians, scientists, pharmaceutical industries and patients - into working solutions.
The building blocks of the programme include plenary talks, scientific debates, and discussions designed to maximise interaction, engagement, open-talks and networking, between all participants and the Faculty of prominent scientific and industry leaders.
Benefit from the exciting opportunity to explore in depth the present challenges and look at the future ways to increase the productivity of biopharmaceutical and clinical innovation, in a realistic and non-biased manner.
Join senior level attendees from leading industry companies, academia and government institutions in Berlin this November to innovate strategically in precision medicine!
The Scientific Advisory Board
Prof. Dan Peer, Israel
Christian Elze, London
Gianni Gromo MD PhD, Switzerland
Prof. Dr Michael Heuser, Germany
Early Registration Deadline: 20 August 2018
For support and exhibition opportunities please visit: https://goo.gl/BVk9XV
